Unlocking the potential of monoclonal antibodies

An experimental Alzheimer’s drug, hailed as a breakthrough, slows cognition decline in people with early-stage disease, according to a new study in the New England Journal of Medicine. The drug, lecanemab, is a monoclonal antibody (mAb) designed Read More »

December 5th, 2022|Announcements, Keck Net Intranet|

HSC personal finance webinar: 3 profitable takeaways

People who are new to the workforce — or have recently switched careers — can face pivotal moments when it comes to developing smart financial habits.

Keck Medicine of USC’s Community of Mentors for Professional Advancement, Support and Success (COMPASS) recently Read More »

November 29th, 2022|Announcements, Keck Net Intranet|

Stephanie Woelfel elected to the National Pressure Injury Advisor Panel board

The National Pressure Injury Advisory Panel (NPIAP) has elected Stephanie Woelfel, PT, DPT, CWS, to its board of directors for a three-year term.

Founded in 1986, the NPIAP is a nonprofit organization dedicated to improving Read More »

November 28th, 2022|Announcements, Keck Net Intranet|

Keck School faculty among world’s most influential researchers

Nine of the Keck School of Medicine of USC’s faculty members have been named to the 2022 list of Highly Cited Researchers by Clarivate.

According to Clarivate, the list recognizes researchers who have “demonstrated significant and broad influence reflected in Read More »

November 22nd, 2022|Announcements, Keck Net Intranet|

Keck School of Medicine of USC and Children’s Hospital Los Angeles awarded $8 million

The California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, has awarded a five-year, $8 million grant to the Keck School of Medicine of USC and Children’s Hospital Los Angeles (CHLA). The Read More »

November 21st, 2022|Announcements, Keck Net Intranet|